Mercy BioAnalytics News and Activities

Acquisition, funding and merger involving Mercy BioAnalytics.

• Mercy BioAnalytics has just announced a $59 Million fundraising (posted on September 5 2025).

View the org chart displaying its 21 main executives

Most searched biographies at Mercy BioAnalytics

• Dawn Mattoon, Chief Executive Officer
• Sonja Perkins, Director
• Rob Freelen, Director

Popular executive movements at Mercy BioAnalytics

• Darrin Crisitello has joined the company as Chief Commercial Officer  (posted on February 5 2026).
• Ellen Snow has joined the company as Chief Financial Officer  (posted on December 5 2025).

Create your alert
to follow the executive moves at Mercy BioAnalytics.

Mercy BioAnalytics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Mercy BioAnalytics

• News and Events | Mercy BioAnalytics
• News and Events | Mercy BioAnalytics
• Press Release Archives - Mercy BioAnalytics

Social media about Mercy BioAnalytics

• Mercy BioAnalytics on Wikipedia, Google News & Yahoo Finance
• Mercy BioAnalytics on LinkedIn, X (Twitter) & YouTube